Chartier-Kastler E, Saad H, Mouquet C, Rudelle E, Benalia H, Luciani J, Bitker M O, Chatelain C
Clinique Urologique, Groupe Hospitalier Pitié-Salpêtrière, Paris.
Prog Urol. 1993 Aug-Sep;3(4):621-6.
From October 1987 to June 1992, 359 renal transplantations were performed, while, over the same period, 25 patients with a follow-up of more than six months underwent repeat renal transplantation: 23 for a second transplant and 2 for a third transplant. The initial disease was glomerular for 17 patients and interstitial for 6 patients. The mean age of the patients at the time of the repeat transplantation was 36.9 years (range: 20 to 53 years). The mean survival after the first transplantation was 3 years and 10 months (range: 1 week to 10 years). The reasons for loss of the first transplant can be classified as follows: acute rejection (n = 5), chronic rejection (n = 14), surgical failure (n = 5) or sepsis (n = 1). 9 patients received conventional immunosuppressant therapy, while 16 patients (64%) received four-drug therapy including cyclosporin. The actuarial one-year survival of the patients and the transplants was 100% and 92%, respectively. The mean serum creatinine was 136.4 +/- 65 mumol/l (range: 59 to 298 mumol/l). Ten patients developed rejection after a mean of 18.6 days (range: 6 to 30 days) and 2 patients suffered from 2 episodes of rejection within 4 months. These results illustrate the low postoperative surgical and immunological complication rate in this group of patients whose long-term results are at least comparable to those of first transplantations in our group.
1987年10月至1992年6月期间,共进行了359例肾移植手术,同期有25例随访时间超过6个月的患者接受了再次肾移植:23例接受第二次移植,2例接受第三次移植。17例患者的初始疾病为肾小球疾病,6例为间质性疾病。再次移植时患者的平均年龄为36.9岁(范围:20至53岁)。首次移植后的平均生存期为3年10个月(范围:1周至10年)。首次移植失败的原因可分类如下:急性排斥反应(n = 5)、慢性排斥反应(n = 14)、手术失败(n = 5)或败血症(n = 1)。9例患者接受传统免疫抑制剂治疗,16例患者(64%)接受包括环孢素在内的四联疗法。患者和移植肾的精算1年生存率分别为100%和92%。平均血清肌酐为136.4±65μmol/L(范围:59至298μmol/L)。10例患者在平均18.6天(范围:6至30天)后发生排斥反应,2例患者在4个月内发生2次排斥反应。这些结果表明,该组患者术后手术和免疫并发症发生率较低,其长期结果至少与我们组首次移植的结果相当。